Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium

Rhabdomyosarcoma is the most common soft tissue sarcoma of childhood. Despite aggressive therapy, the 5-year survival rate for patients with metastatic or recurrent disease remains poor, and beyond PAX-FOXO1 fusion status, no genomic markers are available for risk stratification. We present an inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Shern, Jack F., Selfe, Joanna, Izquierdo, Elisa, Patidar, Rajesh, Chou, Hsien-Chao, Song, Young K., Yohe, Marielle E., Sindiri, Sivasish, Wei, Jun, Wen, Xinyu, Rudzinski, Erin R., Barkauskas, Donald A., Lo, Tammy, Hall, David, Linardic, Corinne M., Hughes, Debbie, Jamal, Sabri, Jenney, Meriel, Chisholm, Julia, Brown, Rebecca, Jones, Kristine, Hicks, Belynda, Angelini, Paola, George, Sally, Chesler, Louis, Hubank, Michael, Kelsey, Anna, Gatz, Susanne A., Skapek, Stephen X., Hawkins, Douglas S., Shipley, Janet M., Khan, Javed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425837/
https://www.ncbi.nlm.nih.gov/pubmed/34166060
http://dx.doi.org/10.1200/JCO.20.03060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425837/
https://www.ncbi.nlm.nih.gov/pubmed/34166060
http://dx.doi.org/10.1200/JCO.20.03060

Ejemplares similares